Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
暂无分享,去创建一个
B. Portmann | R. D. de Man | R. Williams | J. O'grady | P. Burra | M. Bassendine | R. Iemmolo | M. Atkins | N. Naoumov | L. Caccamo | A. Lopes | G. Anschuetz | C. Barrett | Rosamaria Iemmolo | Margaret F. Bassendine | B. Portmann | Patrizia Burra | M. Bassendine | A. Lopes | Lucio Caccamo | Robert A. De Man | J. O'Grady | Catherine A Barrett | Roger Williams | Mark Atkins | Rob A. de Man | L. Caccamo
[1] J. Fung,et al. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[2] J. Sánchez-Tapias,et al. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation , 2000, Hepatology.
[3] C. Scudamore,et al. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[4] P. Angus,et al. Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[5] F. Baldanti,et al. Two Sensitive PCR-Based Methods for Detection of Hepatitis B Virus Variants Associated with Reduced Susceptibility to Lamivudine , 1999, Journal of Clinical Microbiology.
[6] L. Wallace,et al. Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin. , 1999, Journal of hepatology.
[7] C. Chu,et al. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy , 1999, Hepatology.
[8] E. Schiff,et al. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation , 1999, Hepatology.
[9] P. Angus,et al. Combination low dose hepatitis B immune globulin (HBIG) and lamivudine therapy provides effective prophylaxis against post transplant hepatitis B , 1999 .
[10] C. Hunt,et al. Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients. , 1998 .
[11] J. Roberts,et al. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin , 1998, Hepatology.
[12] J. Markmann,et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin , 1998, Hepatology.
[13] N. Leung,et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. , 1998, The New England journal of medicine.
[14] T. Berg,et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high‐dose hepatitis B immune globulin after liver transplantation , 1998, Hepatology.
[15] A. Lok,et al. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis , 1998, Hepatology.
[16] A. Dhillon,et al. Lamivudine and intron a combination treatment in patients with chronic hepatitis B infection , 1998 .
[17] R. D. de Man,et al. Lamivudine resistance inimmunocompetent chronic hepatitis B , 1997 .
[18] R. Repp,et al. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients , 1997, Journal of virology.
[19] D. Samuel,et al. Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. , 1997, Journal of hepatology.
[20] J. Roberts,et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin , 1996, Hepatology.
[21] F. Chisari,et al. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response , 1996, Nature Medicine.
[22] M. Manns,et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis , 1996, Hepatology.
[23] Roger Williams,et al. Hepatitis B envelope protein mutants , 1995, The Lancet.
[24] Mark George Thomas,et al. Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment. , 1995, Gastroenterology.
[25] G. Alexander,et al. 'EUROHEP' consensus report on the management of liver transplantation for hepatitis B virus infection. European Concerted Action on Viral Hepatitis. , 1994, Journal of hepatology.
[26] G. Alexander,et al. Liver transplantation in European patients with the hepatitis B surface antigen. , 1993, The New England journal of medicine.
[27] M. Mearns,et al. Hepatitis B virus DNA in peripheral‐blood mononuclear cells in chronic hepatitis B after HBsAg clearance , 1992, Hepatology.
[28] S. Davies,et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. , 1992, Journal of hepatology.
[29] C. Wittekind,et al. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. , 1991, Journal of hepatology.
[30] D. Samuel,et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients , 1991, The Lancet.
[31] D. V. van Thiel,et al. Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease , 1991, Hepatology.
[32] G. Alexander,et al. Detection of hepatitis B virus antigens in liver tissue. A relation to viral replication and histology in chronic hepatitis B infection. , 1990, Gastroenterology.
[33] D. Samuel,et al. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model. , 1990, Transplantation.